Spurwing

News

GLOBALHealthPR has boosted its Asia-Pacific reach with the addition of Spurwing Communications to its independent med comms network.

News

Merck's drug for tumours associated with rare disease neurofibromatosis type 1, Ezmekly, has been cleared for NHS use in children as young as two.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.